Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: A dietary intervention study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 2, 2010, Pages 117-124

  Sofi, F ^a,b,c   Buccioni, A ^a   Cesari, F ^a   Gori, A M ^a,c   Minieri, S ^a   Mannini, L ^a   Casini, A ^a,b   Gensini, G F ^a,c   Abbate, R ^a   Antongiovanni, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

Cardiovascular disease; Dairy products; Diet; Haemorheology; Inflammation

Indexed keywords

AUTACOID; CHOLESTEROL; CIS 9, TRANS 11 CONJUGATED LINOLEIC ACID; CIS-9, TRANS-11-CONJUGATED LINOLEIC ACID; CONJUGATED LINOLEIC ACID; INTERLEUKIN DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL; ARTICLE; BLOOD; BLOOD RHEOLOGY; BLOOD VISCOSITY; CHEESE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ERYTHROCYTE DEFORMABILITY; FEMALE; HUMAN; MALE; MIDDLE AGED; MILK; SHEEP; THROMBOCYTE AGGREGATION; TIME;

ANIMALS; BLOOD VISCOSITY; CHEESE; CHOLESTEROL; CHOLESTEROL, LDL; CROSS-OVER STUDIES; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMORHEOLOGY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKINS; LINOLEIC ACIDS, CONJUGATED; LIPIDS; MALE; MIDDLE AGED; MILK; PLATELET AGGREGATION; SHEEP; TIME FACTORS; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

OVIS ARIES;

EID: 75349112978     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.03.004     Document Type: Article

References (21)

1. Wahle K.W.J., Heys S.D., and Rotondo D. Conjugated linoleic acids: are they beneficial or detrimental to health?. Prog Lipid Res 43 (2004) 553-587
2. Luna P., Fontecha J., Juarez M., and de la Fuente M.A. Conjugated linoleic acid in ewe milk fat. J Dairy Res 72 (2005) 415-424
3. Dhiman T.R., Nam S.H., and Ure A.L. Factors affecting conjugated linoleic acid content in milk and fat. Crit Rev Food Sci Nutr 45 (2005) 463-482
4. Bhattacharya A., Banu J., Rahman M., Causey J., and Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 17 (2006) 789-810
5. Kuhnt K., Kraft J., Vogelsang H., Eder K., Kratzsch J., and Jahreis G. Dietary supplementation with trans-11-conjugated linoleic acid in human immune cells, but without effects on biomarkers of immune function and inflammation. Br J Nutr 97 (2007) 1196-1205
6. Silveira M.B., Carraro R., Monereo S., and Tebar J. Conjugated linoleic acid (CLA) and obesity. Public Health Nutr 10 (2007) 1181-1186
7. Burdge G.C., Tricon S., Morgan R., Kliem K.E., Childs C., Jones E., et al. Incorporation of cis-9, trans-11 conjugated linoleic acid and vaccenic acid (trans-11 18:1) into plasma and leucocyte lipids in healthy men consuming dairy products naturally enriched in these fatty acids. Br J Nutr 94 (2005) 237-243
8. Association of Official Analytical Chemists.Official Methods of Analysis, AOAC. 15th Edition. Arlington, VA.
9. Folch J., Lees M., and Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226 (1957) 497-509
10. Christie W.W. A simple procedure for rapid trans-methylation of glycerolipids and cholesterol esters. J Lipid Res 23 (1982) 1072-1075
11. Griinari J.M., Dwyer M.A., McGiure M.A., Bauman D.E., Palmquist D.L., and Nurmela K.V. Trans-octa-decenoic acids and milk fat depression in lactating dairy cows. J Dairy Sci 81 (1998) 1251-1261
12. Kramer J.K.G., Cruz-Hernandez C., Deng Z.Y., Zhou J.Q., Jahreis G., and Dugan M.E.R. Analysis of conjugated linoleic acid and trans 18:1 isomers in synthetic and animal products. Am J Clin Nutr 79 (2004) 1137S-1145S
13. Addis M., Cabiddu A., Pinna G., Decandia M., Piredda G., Pirisi A., et al. Milk and cheese fatty acid composition in sheep fed Mediterranean forages with reference to conjugated linoleic acid cis-9, trans-11. J Dairy Sci 88 (2005) 3443-3454
14. Nestel P., Fujii A., and Allen T. The cis-9, trans-11 isomer of conjugated linoleic acid (CLA) lowers plasma triglyceride and raises HDL cholesterol concentrations but does not suppress aortic atherosclerosis in diabetic apoE-deficient mice. Atherosclerosis 189 (2006) 282-287
15. Tricon S., Burdge G.C., Kew S., Banerjee T., Russell J.J., Jones E.L., et al. Opposing effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 80 (2004) 614-620
16. Tricon S., Burdge G.C., Jones E.L., Russell J.J., El-Khazen S., Moretti E., et al. Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am J Clin Nutr 83 (2006) 744-753
17. Tholstrup T., Raff M., Straarup E.M., Lund P., Basu S., and Bruun J.M. An oil mixture with trans-10, cis-12 conjugated linoleic acid increases markers of inflammation and in vivo lipid peroxidation compared with cis-9, trans-11 conjugated linoleic acid in postmenopausal women. J Nutr 138 (2008) 1445-1451
18. Moloney F., Toomey S., Noone E., Nugent A., Allan B., Loscher C.E., et al. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 56 (2007) 574-582
19. Remakers J.D., Plat J., Sebedio J.L., and Mensink R.P. Effects of individual isomers cis-9, trans-11 vs. trans-10, cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B. Lipids 40 (2005) 909-918
20. Sofi F, Cesari F, Gori AM, Paniccia R, Mannini L, Giorgi G, et al. Lipid, inflammatory, and haemorheological profiles are significantly affected by farmed fish eating: an intervention study.Int J Food Nutr; in press, doi:10.1080/02652040802379399.
21. Marcucci R., Gori A.M., Paniccia R., Giglioli C., Buonamici P., Antoniucci D., et al. Residual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapy. Atherosclerosis 49 (2007) 2312-2317